Is Our DNA in Safe Hands? What the Regeneron Acquisition of 23andMe Means for Security and Privacy
When Regeneron announced its $256 million acquisition of 23andMe, most headlines focused on drug discovery potential. But beneath the surface lies a deeper concern: the fate of 15 million genetic profiles. At Sekurno, we unpack the post-acquisition security risks, Regeneron’s breach history, and why compliance alone isn’t enough to protect the world’s most personal data—your DNA.
Sekurno
2 days ago4 min read